SCOPUS 정보 검색 플랫폼

Pharmaceutical Technology Europe

Volumn 18, Issue 10, 2006, Pages 25-30

Carriers for DPIs: Formulation and regulatory challenges

(5) Kaerger, J Sebastian a Price, Robert b Young, Paul M c Edge, Stephen a Tobyn, Michael J b

a NOVARTIS PHARMA AG (Switzerland)

b UNIVERSITY OF BATH (United Kingdom)

c UNIVERSITY OF SYDNEY (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA LACTOSE; BUDESONIDE; CHYMOSIN; FLUTICASONE PROPIONATE PLUS SALMETEROL; LACTOSE; MIFLONIDE; PULVINAL; SALBUTAMOL;

AEROSOL; ARTICLE; BOVINE SPONGIFORM ENCEPHALOPATHY; DISEASE TRANSMISSION; DRUG DELIVERY SYSTEM; DRUG DESIGN; DRUG FORMULATION; DRUG IMPURITY; DRUG MEGADOSE; DRUG PENETRATION; DRY POWDER; GOOD MANUFACTURING PRACTICE; LOW DRUG DOSE; PARTICLE SIZE; PATENT; PHYSICAL CHEMISTRY; POWDER INHALER; PROTEIN ANALYSIS; RISK ASSESSMENT; X RAY PHOTOELECTRON SPECTROSCOPY;

EID: 33749320377 PISSN: 01646826 EISSN: None Source Type: Journal
DOI: None Document Type: Article

Times cited : (7)

References (15)

1
- 0037346651
- I.J. Smith and M. Parry-Billings, Pulm. Pharmacol. Ther. 16, 79-95 (2003).
- (2003) Pulm. Pharmacol. Ther. , vol.16 , pp. 79-95
- Smith, I.J.¹ Parry-Billings, M.²

2
- 0036862037
- H. te Wierik, P. Diepenmaat and R. Damhuls, Pharm. Technol. Eur. 14(11), 47-52 (2002).
- (2002) Pharm. Technol. Eur. , vol.14 , Issue.11 , pp. 47-52
- Wierik te, H.¹ Diepenmaat, P.² Damhuls, R.³

3
- 33749362513
- Poster Contribution T3251
- November 6-10, presented at the Nashville, TN, USA
- K. Kussendrager et. al., Poster Contribution T3251, presented at the AAPS Annual Meeting, Nashville, TN, USA, November 6-10, 2005.
- (2005) AAPS Annual Meeting
- Kussendrager, K.¹

4
- 23144462230
- Technical Note 1
- G. Buckton et. al., AAPS PharmSciTech. 3(4), Technical Note 1 (2002). www.aapspharmscitech.org
- (2002) AAPS PharmSciTech. , vol.3 , Issue.4
- Buckton, G.¹

5
- 33749352221
- Poster Contribution W4233
- November 6-10, presented at the Nashville, TN, USA
- S. Ebbens et. al., Poster Contribution W4233, presented at the AAPS Annual Meeting, Nashville, TN, USA, November 6-10, 2005.
- (2005) AAPS Annual Meeting
- Ebbens, S.¹

6
- 1542407024
- A. Nowak-Wegrzyn et. al., J. Allergy Clin. Immunol. 113, 558-560 (2004).
- (2004) J. Allergy Clin. Immunol. , vol.113 , pp. 558-560
- Nowak-Wegrzyn, A.¹

7
- 33749317819
- Novartis internal report
- S. Kaerger Novartis internal report (2005).
- (2005)
- Kaerger, S.¹

8
- 5444245079
- M.E. Thomas et al., Crit. Rev. Food Sci. Nutr. 44, 297-322 (2004).
- (2004) Crit. Rev. Food Sci. Nutr. , vol.44 , pp. 297-322
- Thomas, M.E.¹

9
- 0030855048
- P. Baldrick and D.G. Bamford, Food Chem. Toxicol. 35, 719-733 (1997).
- (1997) Food Chem. Toxicol. , vol.35 , pp. 719-733
- Baldrick, P.¹ Bamford, D.G.²

10
- 33749346977
- EMEA, Risk and regulatory assessment of lactose and other products prepared using calf rennet (EMEA, 7 Westferry Circus, Canary Wharf, London, EH14 7HB, UK)
- EMEA, Risk and regulatory assessment of lactose and other products prepared using calf rennet (EMEA, 7 Westferry Circus, Canary Wharf, London, EH14 7HB, UK). www.emea.eu.int/pdfs/human/bwp/033702en.pdf

11
- 33749355848
- ICH, Quality 8 (ICH, 15, chemin Louis-Dunant, P.O. Box 195, 1211 Geneva 20, Switzerland, May
- ICH, Quality 8 (ICH, 15, chemin Louis-Dunant, P.O. Box 195, 1211 Geneva 20, Switzerland, May 2006). www.ich.org/LOB/media/MEDIA1707.pdf
- (2006)

12
- 33749369451
- S. Moss, Business Briefing Pharmtech., 71-75 (2004).
- (2004) Business Briefing Pharmtech. , pp. 71-75
- Moss, S.¹

13
- 33749329013
- P. Begat et. al., KONA 23, 109-121 (2005).
- (2005) KONA , vol.23 , pp. 109-121
- Begat, P.¹

14
- 0347021194
- H. Steckel and N. Bolzen, Int. J. Pharm. 270, 297-306 (2004).
- (2004) Int. J. Pharm. , vol.270 , pp. 297-306
- Steckel, H.¹ Bolzen, N.²

15
- 22544457534
- H.D.C. Smyth and A.J. Hickey, Am.J. Drug Deliv. 3(2), 117-132 (2005).
- (2005) Am. J. Drug Deliv. , vol.3 , Issue.2 , pp. 117-132
- Smyth, H.D.C.¹ Hickey, A.J.²

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.